LetterLetter
Development of Nephrotic Syndrome in a Patient with Rheumatoid Arthritis Treated with Certolizumab
RONALD R. BUTENDIECK JR., TANYA BHATTACHARYA and XOCHIQUETZAL GEIGER
The Journal of Rheumatology September 2016, 43 (9) 1770-1772; DOI: https://doi.org/10.3899/jrheum.160147
RONALD R. BUTENDIECK JR.
Division of Rheumatology, Department of Medicine, Mayo Clinic;
MDRoles: Assistant Professor of Medicine
TANYA BHATTACHARYA
Preliminary Internal Medicine Resident, Department of Medicine, Mayo Clinic;
MDXOCHIQUETZAL GEIGER
Assistant Professor of Laboratory Medicine and Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, Florida,
USA.
MDREFERENCES
In this issue
The Journal of Rheumatology
Vol. 43, Issue 9
1 Sep 2016
Development of Nephrotic Syndrome in a Patient with Rheumatoid Arthritis Treated with Certolizumab
RONALD R. BUTENDIECK, TANYA BHATTACHARYA, XOCHIQUETZAL GEIGER
The Journal of Rheumatology Sep 2016, 43 (9) 1770-1772; DOI: 10.3899/jrheum.160147